Clinical Trial

First Evaluation of a Craniofacial Nerve Stimulation System in Chronic Migraine

Study acronym: SalviaBio
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to demonstrate the safe use of the PRIMUS system in subjects with chronic migraine. This is a single-center, open label, prospective, early feasibility study to collect initial clinical data on the PRIMUS system for the treatment of chronic migraine.
Protocol Amendment History 1 change
minor Completion pushed: 2026-12-31 -> 2027-12-31 2026-07-10
Trial Details
NCT Number NCT05858801
Lead Sponsor Salvia BioElectronics
Conditions Chronic Migraine
Enrollment 7 participants
Start Date 2023-05-09
Primary Completion 2023-12-09 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09